business analyst

Synthetic biology moves us from reading to writing DNA, allowing us to design biological systems from scratch for any number of applications. Its capabilities are becoming clearer, its first products and processes emerging. Synthetic biology’s reach already extends from reducing our dependence on oil to transforming how we develop medicines and food crops. It is being heralded as the next big thing; whether it fulfils that expectation remains to be seen. It will require collaboration and multi-disciplinary approaches to development, application and regulation. Interesting times ahead!

Via Szabolcs Kósa

Synthetic Biology promises low-cost, exponentially scalable products and global health solutions in the form of self-replicating organisms, or “living devices.” As these promises are realized, proof-of-concept systems will gradually migrate from tightly regulated laboratory or industrial environments into private spaces as, for instance, probiotic health products, food, and even do-it-yourself bioengineered systems. What additional steps, if any, should be taken before releasing engineered self-replicating organisms into a broader user space?

Via Gerd Moe-Behrens, Szabolcs Kósa